tolamolol has been researched along with Kidney Failure, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balant, LP; Dayer, P; Fabre, J | 1 |
| Balant, L; Gorgia, A; Marmy, A; Tschopp, JM | 1 |
1 review(s) available for tolamolol and Kidney Failure, Chronic
| Article | Year |
|---|---|
Consequences of renal insufficiency on the hepatic clearance of some drugs.
Topics: Adrenergic beta-Antagonists; Biotransformation; Dextropropoxyphene; Ethanolamines; Humans; Kidney Diseases; Kidney Failure, Chronic; Kinetics; Liver; Models, Biological; Oxprenolol; Pharmaceutical Preparations; Propanolamines; Propranolol; Renal Dialysis | 1983 |
1 other study(ies) available for tolamolol and Kidney Failure, Chronic
| Article | Year |
|---|---|
[Clearance concept applied to pharmacokinetics: 2. Experience with tolamolol (beta-blocking agent) in renal insufficiency (author's transl)].
Topics: Adult; Aged; Biotransformation; Female; Half-Life; Humans; Hydroxylation; Intestinal Absorption; Kidney Failure, Chronic; Kinetics; Liver; Male; Middle Aged; Propanolamines | 1980 |